Partial recovery of left ventricular function in dilated cardiomyopathy as a result of tuberculosis treatment
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 4, Issue 2
Abstract
We present the case of a young patient with dilated cardiomyopathy (DCM) and concomitant pulmonary tuberculosis (TB), emphasising the need for an interdisciplinary approach when considering underlying aetiology. A 36‐year‐old male was admitted to the hospital due to signs of acute heart failure (HF). After diagnostic work‐up, which included laboratory examination, echocardiography, and coronary angiography, a diagnosis of DCM was established and therapy was initiated. Despite optimal medical therapy for HF, the patient’s condition did not improve. During further diagnostic workup, pulmonary tuberculosis was identified. A significant reduction in HF signs and symptoms and improvement in left ventricular ejection fraction occurred only after TB was treated with 6 months of therapy. The presented case study illustrates the necessity to perform a complete diagnostic workup to identify reversible causes of DCM. JRCD 2019; 4 (2): 56-58
Authors and Affiliations
Antoni Zdzisław Wileczek, Małgorzata Trawińska, Sebastian Stec
Keywords
Related Articles
- EP ID EP630625
- DOI 10.2041/jrcd.vol4no2.371
- Views 100
- Downloads 0
Nitric oxide signaling in the ischemic postconditioning of human heart muscle (RCD code: III)
Background: Ischemic heart conditioning is well documented to trigger the intrinsic protective mechanisms of resistance against ischemia/reperfusion (I/R) injury. Previous studies on animal model have suggested that the...
The 4th Conference of Working Group in Congenital Heart Diseases of Polish Society of Cardiology
Congenital heart disease (CHD) is the most common developmental anomaly and represents about 1% of all live-born children. Recent progress in cardiac surgery and pediatric cardiology has resulted in large numbers of adu...
Doxorubicin cardiomyopathy – case report and review of histopathologic findings (RCD code: III‐1B.5a)
The anthracycline anticancer drug Doxorubicin (Adriamycin) is an effective and frequently used chemotherapeutic agent for various malignancies. The use of doxorubicin is limited by its major adverse effect, cardiotoxicit...
Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of com...
Long QT syndrome diagnosed in the postpartum period (RCD code: VII-V-1A.2)
We report a case of 22 years old woman with long QT syndrome type with the first cardiac incidents in the post partum period. We discuss the actual treatment recommendation in the long QT syndrome with special attention...